Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

被引：0
|
作者：
Liu, Wei [1 ,2 ]
Xue, Feng [1 ,2 ]
Fu, Rongfeng [1 ,2 ]
Ding, Bingjie [3 ,4 ]
Li, Mengjuan [1 ,2 ]
Sun, Ting [1 ,2 ]
Chen, Yunfei [1 ,2 ]
Liu Xiaofan [1 ,2 ]
Ju, Mankai [1 ,2 ]
Dai, Xinyue [1 ,2 ]
Wu, Quanrui [5 ]
Zhou, Zan [5 ]
Wang, Xiaomin [5 ]
Yu, Jiaojiao [5 ]
Zhou, Hu [3 ,4 ]
Yang, Renchi [1 ,2 ]
Zhang, Lei [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
[3] Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Henan Canc Hosp, Hemostasis & Thrombosis Diagnost Engn Res Ctr Hen, Zhengzhou, Peoples R China
[5] Staidson Beijing Biopharmaceut Co Ltd, Beijing, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159948
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8474 / 8475
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of three herbal medicinal products in patients with acute bronchitis: a multi-center, randomized, open-label clinical trial
    de Zeeuw, J.
    Kehr, M. S.
    Braun, S.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S542 - S542
  • [22] Memantine Treatment in Patients with Alzheimer's Disease: Neuropsychological Results from an Open-Label, Multi-Center Brain Imaging Trial
    Saxton, Judith
    Hofbauer, Robert K.
    Graham, Stephen
    Yu, Sung Yun
    Li, Shaoyi
    Hsu, Hai-An
    Perhach, James L.
    NEUROLOGY, 2009, 72 (11) : A382 - A383
  • [23] Memantine Treatment in Patients with Alzheimer's Disease: Neuropsychological Results from an Open-Label, Multi-Center Brain Imaging Trial
    Hofbauer, Robert K.
    Graham, Stephen M.
    Saxton, Judith
    Yu, Sung Y.
    Li, Shaoyi
    Hsu, Hai-An
    Perhach, James L.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A79 - A80
  • [24] Serpinpc in Persons with Severe Hemophilia (PwH): Updated Results from a Multi-Center, Multi-Part, First-in-Human Study
    Baglin, Trevor
    Koch, Annelize
    Mocanu, Irina
    Makhaldiani, Levani
    Huntington, James A.
    BLOOD, 2022, 140
  • [25] A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer
    Hwang, In Gyu
    Ji, Yin Ho
    Kang, Jung Hun
    Lee, Hyo Rak
    Lee, Hui-Young
    Chi, Kyong-Choun
    Park, Suk Won
    Lee, Su Jin
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (03) : 170 - 175
  • [26] Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
    Alberer, Martin
    Gnad-Vogt, Ulrike
    Hong, Henoch Sangjoon
    Mehr, Keyvan Tadjalli
    Backert, Linus
    Finak, Greg
    Gottardo, Raphael
    Bica, Mihai Alexandru
    Garofano, Aurelio
    Koch, Sven Dominik
    Fotin-Mleczek, Mariola
    Hoerr, Ingmar
    Clemens, Ralf
    von Sonnenburg, Frank
    LANCET, 2017, 390 (10101): : 1511 - 1520
  • [27] Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial
    Kuwabara, Satoshi
    Misawa, Sonoko
    Mori, Masahiro
    Iwai, Yuta
    Ochi, Kazuhide
    Suzuki, Hidekazu
    Nodera, Hiroyuki
    Tamaoka, Akira
    Iijima, Masahiro
    Toda, Tatsushi
    Yoshikawa, Hiroo
    Kanda, Takashi
    Sakamoto, Ko
    Kusunoki, Susumu
    Sobue, Gen
    Kaji, Ryuji
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (02) : 115 - 119
  • [28] Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients
    Zwaginga, Jaap J.
    van der Holt, Bronno
    te Boekhorst, Peter A.
    Biemond, Bart J.
    Levin, Mark-David
    van der Griend, Rene
    Brand, Anneke
    Zweegman, Sonja
    Pruijt, Hans F. M.
    Novotny, Vera M. J.
    Vreugdenhil, Art
    de Groot, Marco R.
    de Weerdt, Okke
    van Pampus, Elisabeth C. M.
    van Maanen-Lamme, Tanja M.
    Wittebol, Shulamiet
    Schipperus, Martin R.
    Silbermann, Matthijs H.
    Huijgens, Peter C.
    Luten, Marleen
    Hollestein, Rene
    Brakenhoff, Jan A. C.
    Schrama, Jolanda G.
    Valster, Fransje A. A.
    Velders, Gerjo A.
    Koene, Harry R.
    HAEMATOLOGICA, 2015, 100 (03) : E90 - E92
  • [29] Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study
    Reid, Tony
    Oronsky, Bryan
    Scicinski, Jan
    Scribner, Curt L.
    Knox, Susan J.
    Ning, Shoucheng
    Peehl, Donna M.
    Korn, Ron
    Stirn, Meaghan
    Carter, Corey A.
    Oronsky, Arnold
    Taylor, Michael J.
    Fitch, William L.
    Cabrales, Pedro
    Kim, Michelle M.
    Burris, Howard A.
    Lao, Christopher D.
    Abrouk, Nacer E. D.
    Fanger, Gary R.
    Infante, Jeffrey R.
    LANCET ONCOLOGY, 2015, 16 (09): : 1133 - 1142
  • [30] A phase 1, multicenter, open-label, first-in-human study of DS-6157a in patients (pts) with advanced gastrointestinal stromal tumor (GIST).
    George, Suzanne
    Heinrich, Michael C.
    Somaiah, Neeta
    Van Tine, Brian Andrew
    McLeod, Robert
    Laadem, Abderrahmane
    Cheng, Ben
    Nishioka, Satoshi
    Kundu, Madan Gopal
    Qian, Xiaozhong
    Lau, Yvonne Y.
    Tran, Brittany
    Kumar, Prasanna
    Dosunmu, Ololade
    Shi, Julia
    Naito, Yoichi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345